These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 5300283

  • 1. [A scheme of triple reserve drugs in the treatment of resistant forms of pulmonary tuberculosis].
    Rizzo A, Magalhães M, Moura N.
    Hospital (Rio J); 1966 Sep; 70(3):767-83. PubMed ID: 5300283
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Comparison of combination therapy of Capreomycin, ethionamide and cycloserin with that of kanamycin, ethionamide and cycloserin for the retreatment of pulmonary tuberculosis].
    Kitamoto O, Oka S, Kawamori Y, Gomi J, Sugiyama K.
    Saishin Igaku; 1970 Jul 10; 25(7):1546-55. PubMed ID: 5451178
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of kanamycin in a triple regimen of kanamycin, cycloserine and ethionamide in the treatment of far-advanced cases of pulmonary tuberculosis with tubercle bacilli resistant to primary drugs.
    Oka S, Motomiya M, Kato S, Sato H, Fujimoto M.
    Sci Rep Res Inst Tohoku Univ Med; 1967 Apr 10; 14(1):91-3. PubMed ID: 4968094
    [No Abstract] [Full Text] [Related]

  • 5. [Th 13-14 and PZA and CS in the treatment of chronic cavitary tuberculosis with bacterial resistance to classic antibacterial drugs].
    Zunić D.
    Tuberkuloza; 1966 Apr 10; 18(5):429-40. PubMed ID: 16296047
    [No Abstract] [Full Text] [Related]

  • 6. [Autonomic drug therapy with delayed action drugs in pulmonary tuberculosis (chronic-drug therapy resistant patients, without immediate surgical possibilities)].
    Bethlem N, Mendes W.
    Hospital (Rio J); 1968 Jul 10; 74(1):1-5. PubMed ID: 5305552
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative studies of various antituberculosis drug regimens by means of serum antimycobacterial activity tests in man.
    Hokama S.
    Jpn J Tuberc; 1967 Jul 10; 14(1):55-65. PubMed ID: 5300098
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Administration of reserve antitubercular drugs in a single daily dose].
    Bek E, Bukalska Z, Zachara A.
    Gruzlica; 1968 Jul 10; 37(1):43-7. PubMed ID: 5720037
    [No Abstract] [Full Text] [Related]

  • 11. [Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
    Fegiz G.
    Policlinico Prat; 1967 Oct 23; 74(43):1454-62. PubMed ID: 5629122
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of pulmonary tuberculosis in patients resistant to major drugs with second line drugs].
    Ibarra JP, Piñeyro J, Trenchi A, Tarallo NH, Lanne de Farriols ME, Cuñarro de Gimeno G, Fernández Latorre I.
    Hoja Tisiol; 1967 Oct 23; 24(1):5-88. PubMed ID: 4308762
    [No Abstract] [Full Text] [Related]

  • 14. [Autonomous treatment of pulmonary tuberculosis with delayed-action drugs].
    Pannain M, Tarantino AB, Mac Dowell A, Costa JA, Cunha JM, Pantoja W.
    Rev Bras Med; 1967 Aug 23; 24(8):664-8. PubMed ID: 5603007
    [No Abstract] [Full Text] [Related]

  • 15. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
    Kam KM, Yip CW.
    Int J Tuberc Lung Dis; 2004 Jun 23; 8(6):760-6. PubMed ID: 15182147
    [Abstract] [Full Text] [Related]

  • 16. Treatment of patients with drug-resistance in economically developed countries.
    Crofton J.
    Tubercle; 1969 Mar 23; 50():Suppl:65-8. PubMed ID: 4319134
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R, Verma SK, Sahai S, Kumar S, Jain A.
    Indian J Chest Dis Allied Sci; 2006 Mar 23; 48(3):183-6. PubMed ID: 18610675
    [Abstract] [Full Text] [Related]

  • 18. A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.
    Bignall JR.
    Bull Int Union Tuberc; 1968 Dec 23; 41():175-7. PubMed ID: 4885379
    [No Abstract] [Full Text] [Related]

  • 19. [Comparative study of two regimens, KM-TH-CS and KM-TH-EB, in retreatment cases of pulmonary tuberculosis].
    Aoyagi T, Fukuhara Y, Hondo G, Matsumiya T, Murata A.
    Kekkaku; 1970 Jan 23; 45(1):27-36. PubMed ID: 5416951
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.